The Pharmaceutical Journal
Vol 270 No 7253 p820
14 June 2003

This article
Reprint
Photocopy

News summary

Conference summaries  24 May   31 May   7 June   14 June

Related websites
American Thoracic Society conference 2003 (more)

Ciprofloxacin targets lungs

A method for targeting ciprofloxacin to lung tissue has been developed. The quinolone antibiotic is encapsulated with liposome and an antibody specific for a lung vascular protein. Researchers reported at the American Thoracic Society conference that this method could enhance bacterial clearance and reduce the problem of drug-resistance. Clinical trials for pneumonia and cystic fibrosis are planned.

The Journal attended the American Thoracic Society annual conference, held in Seattle, Washington last month, as a guest of GlaxoSmithKline